Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4799-4803, September 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Priebe, T.
Right arrow Articles by Nelson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priebe, T.
Right arrow Articles by Nelson, J. A.

Selective Modulation of Antibody Response and Natural Killer Cell Activity by Purine Nucleoside Analogues1

Teresa Priebe, Osama Kandil, Melita Nakic, Bih Fang Pan and J. Arly Nelson2

Department of Experimental Pediatrics, University of Texas-M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030

Analogues that are poor substrates for adenosine deaminase or purine nucleoside phosphorylase may mimic immunodeficiencies associated with the enzyme deficiencies, and their activities may be directed toward selected lymphocyte subpopulations. Four analogues were studied for their effects on primary antibody response to either a T-dependent (sheep erythrocytes) or T-independent (trinitrophenyl-conjugated Escherichia coli lipopolysaccharide) antigen as well as effects on T-cytotoxic and natural killer cell activities in mice. The nucleosides were: an adenosine analogue, tubercidin; two deoxyadenosine analogues, 2-chloro, 2'-deoxyadenosine and 2-fluoroadenine arabinoside-5'-phosphate; and a deoxyguanosine analogue, 9-ß-D-arabinosylguanine. Drugs were given i.p. once daily for 3 consecutive days. Immune responses were determined in spleen cell suspensions 1 day after the last dose. Tubercidin inhibited both T-cytotoxic and natural killer cell activities at doses that did not reduce primary antibody response, whereas the reverse was true for 2-chloro, 2'-deoxyadenosine and 2-fluoroadenine arabinoside-5'-phosphate. At higher doses, T-cytotoxic lymphocytes appeared to be more sensitive than natural killer cells to the deoxyadenosine analogues. 9-ß-D-Arabinosylguanine did not selectively inhibit the immune responses at doses that clearly reduced the yield of spleen lymphocytes. Assuming the analogues mimic endogenous nucleosides, the results suggest that natural killer cells are more sensitive to adenosine than are those cells responsible for primary antibody response, whereas the reverse is true for deoxyadenosine.

1 Supported by Grant HD-13951 from the Institute for Child Health and Human Development and Grant CA-28034 from the National Cancer Institute, the NIH.

2 To whom requests for reprints should be addressed at Department of Experimental Pediatrics, University of Texas-M. D. Anderson Hospital and Tumor Institute, 1515 Holcombe Blvd., Houston, TX 77030.

Received 12/23/87. Revised 4/27/88. Accepted 6/ 6/88.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
C Weidler, C Holzer, M Harbuz, R Hofbauer, P Angele, J Scholmerich, and R H Straub
Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium
Ann Rheum Dis, January 1, 2005; 64(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. O. Rodriguez Jr, C. M. Stellrecht, and V. Gandhi
Mechanisms for T-cell selective cytotoxicity of arabinosylguanine
Blood, September 1, 2003; 102(5): 1842 - 1848.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.